+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

S

Actively Recruiting

Healthy Volunteer

Researchers are studying the wide range of schizophrenia and related psychotic disorders in children and adolescents aged 7 to 20 years. The study aims to identify clinical subgroups within this population and determine if these groups predict how patients respond to specific antipsychotic medications. This research involves collaboration across five sites in France and includes both clinical and biological data collection to better understand these conditions. The study involves comprehensive assessments including diagnostic interviews, developmental histories, cognitive testing, neuroimaging MRI, and DNA analyses when patients and families agree. Participants will be monitored over time with follow-up visits scheduled at 1, 3, and 5 years to evaluate treatment responses and changes in clinical and cognitive status. These assessments include evaluating the Lifetime Dimensions of Psychosis Scale in children and adolescents. Participants will undergo medical and neuropsychological evaluations, speech and language assessments, and complete questionnaires related to psychosis symptoms. MRI scans and blood samples for genetic testing may be collected if consented. Researchers will track clinical changes, cognitive function, and treatment effects using specific scales during follow-up. The main outcome measured is the Lifetime Dimensions of Psychosis Scale at 4 months, with additional long-term evaluations up to 5 years. The total duration of participation spans several years with periodic assessments.

Age: 7Years - 20YearsAll GendersPhase Not Applicable
6 locations
O

Actively Recruiting

This research is focused on evaluating the feasibility of conducting initial screening for bronchopulmonary cancer using chest CT scans in a French population within a coordinated and efficient network at pilot centers. The study aims to organize bronchopulmonary cancer screening in the Ile de France region through a clear and functional process, including eligibility criteria based on the NELSON study, and coordinated referrals for consultations, CT scans, and follow-up care. Participants undergo screening CT scans according to the NELSON trial schedule at inclusion, 1 year, 3 years, and 5.5 years. The screening process includes referral by trained physicians, structured centralized reading of CT images, multidisciplinary team review for suspected cancers, referral to smoking cessation programs for current smokers, and organized follow-up within the screening program. During the study, participants will complete an online self-questionnaire and attend an inclusion visit at a health center. Researchers will assess completion rates of CT scans at specified time points, smoking cessation rates, detection rates of early-stage bronchopulmonary cancers, and rates of complications related to further examinations. The primary outcome includes the rate of initial CT scans for screening over 36 months, with ongoing monitoring and follow-up planned through 5.5 years. The total study duration extends until 2034.

Age: 50Years - 74YearsAll GendersPhase Not Applicable
9 locations